Overview

Effects of an Opioid Free/Sparing Care Pathway for Patients Undergoing Obesity Surgery

Status:
Recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
The opioid consumption has exploded in the western world 1, and for some patient populations such as obese patients, patients with sleep apnoea or patients undergoing cancer treatment, opioid-sparing/ opioid-free strategies could have positive effects on outcomes. Studies suggest that opioids could have opioid-induced immunosuppression, induce chronic post-operative pain syndrome and hyperalgesia in addition to the more well-known side effects such as respiratory depression, nausea, bladder, and bowel dysfunction. Hence, new studies are needed on the impact of person-centered care programs that combine pharmaceutical and non-pharmaceutical strategies to reduce the adverse short and long-term effects of opioid therapy.
Phase:
N/A
Details
Lead Sponsor:
Göteborg University
Treatments:
Analgesics, Opioid
Anesthetics
Desflurane
Dexmedetomidine
Esketamine
Isoflurane
Lidocaine
Oxycodone
Propofol
Remifentanil